KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 50 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $963,000 | -74.6% | 100,000 | -50.0% | 0.32% | -62.5% |
| Q4 2020 | $3,798,000 | -13.8% | 200,000 | -42.9% | 0.85% | -33.6% |
| Q3 2020 | $4,407,000 | +4.1% | 350,000 | 0.0% | 1.27% | +14.1% |
| Q2 2020 | $4,235,000 | +58.1% | 350,000 | 0.0% | 1.12% | +57.3% |
| Q1 2020 | $2,678,000 | -63.8% | 350,000 | -15.7% | 0.71% | -49.6% |
| Q4 2019 | $7,391,000 | +102.3% | 415,000 | +31.7% | 1.41% | +51.2% |
| Q3 2019 | $3,654,000 | -45.0% | 315,000 | +5.0% | 0.93% | -32.4% |
| Q2 2019 | $6,645,000 | -42.0% | 300,000 | -25.0% | 1.38% | -53.9% |
| Q1 2019 | $11,448,000 | +36.4% | 400,000 | -5.9% | 2.99% | -1.8% |
| Q4 2018 | $8,394,000 | +68.7% | 425,000 | +88.9% | 3.05% | +188.2% |
| Q3 2018 | $4,975,000 | – | 225,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 589,270 | $8,686,000 | 5.61% |
| GREAT POINT PARTNERS LLC | 874,197 | $12,886,000 | 3.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 383,233 | $10,805,000 | 2.44% |
| Frazier Life Sciences Management, L.P. | 1,572,192 | $23,174,000 | 1.98% |
| TANG CAPITAL MANAGEMENT LLC | 648,269 | $9,555,000 | 1.91% |
| Deep Track Capital, LP | 1,729,757 | $25,497,000 | 1.64% |
| Vivo Capital, LLC | 1,533,559 | $22,605,000 | 1.56% |
| Monashee Investment Management LLC | 264,111 | $3,893,000 | 1.13% |
| COMMODORE CAPITAL LP | 312,553 | $4,607,000 | 1.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 | $25,740,000 | 0.79% |